JoVE Logo

Iniciar sesión

5.7 : Phase II Conjugation Reactions: Overview

Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological activity, conjugation effectively ends drug action and facilitates safe excretion. Phase I reactions often prepare molecules for this process by introducing functional groups, making conjugation a crucial step in comprehensive drug metabolism.

Conjugation reactions are highly specific, occurring between distinct functional groups on the drug or metabolite and the conjugating agent. These agents, such as glucuronic acid and sulfate, are abundant in the body, making them readily available for these reactions. The capacity for conjugation varies among different drugs and functional groups, with some drugs being more prone to conjugation than others. The formation of conjugates through phase II reactions significantly increases their molecular weight, boosting their water solubility and facilitating their excretion. Conjugates are typically expelled from the body through renal excretion via urine or biliary excretion via bile.

Tags

Phase II ConjugationBiotransformationDrug DetoxificationGlucuronic AcidSulfateGlycineConjugation ReactionsEnzyme CatalysisInactive MetabolitesWater soluble FormsDrug MetabolismPharmacological ActivityFunctional GroupsRenal Excretion

Del capítulo 5:

article

Now Playing

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

151 Vistas

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

309 Vistas

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

226 Vistas

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

135 Vistas

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

59 Vistas

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

173 Vistas

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

70 Vistas

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

249 Vistas

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

155 Vistas

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

135 Vistas

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

169 Vistas

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

122 Vistas

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

35 Vistas

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

167 Vistas

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

100 Vistas

JoVE Logo

Privacidad

Condiciones de uso

Políticas

Investigación

Educación

ACERCA DE JoVE

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados